The cartilage chondrolytic mechanism of fibronectin fragments involves MAP kinases: comparison of three fragments and native fibronectin

Osteoarthritis and Cartilage

Volumn 16, Issue 10, 2008, Pages 1253-1262

  Ding, L ^a   Guo, D ^a   Homandberg, G A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cartilage; Cartilage chondrolysis; Chondrocytes; Fibronectin; Fibronectin fragments; MAP kinases; Matrix metalloproteinases

Indexed keywords

COLLAGENASE 3; FIBRONECTIN; GELATIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEOGLYCAN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL LYSATE; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FLUORESCENCE MICROSCOPY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIAL FLUID; UPREGULATION;

ANIMALS; CARTILAGE; CATTLE; CELLS, CULTURED; CHONDROCYTES; FIBRONECTINS; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS;

EID: 50949116784     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.02.015     Document Type: Article

References (63)

1. Homandberg G.A., Meyers R., and Xie D.L. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267 (1992) 3597-3604
2. Xie D.L., and Homandberg G.A. Fibronectin fragments bind to and penetrate cartilage tissue resulting in proteinase expression and cartilage damage. Biochim Biophys Acta 1182 (1993) 189-196
3. Xie D.L., Hui F., Meyers R., and Homandberg G.A. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys 311 (1994) 205-212
4. Bewsey K., Wen C., Purple C., and Homandberg G.A. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture. Biochim Biophys Acta 1317 (1996) 55-64
5. Xie D.L., Hui F., and Homandberg G.A. Fibronectin fragments reversibly alter matrix protein synthesis in cartilage in vitro. Arch Biochem Biophys 307 (1993) 110-118
6. Homandberg G.A., and Hui F. High concentrations of fibronectin fragments cause short term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys 311 (1994) 213-218
7. Homandberg G.A., and Wen C. Exposure of cartilage to a fibronectin fragment amplifies catabolic processes while also enhancing anabolic processes to limit damage. J Orthop Res 16 (1998) 237-246
8. Homandberg G.A., Hui F., Wen C., Purple C., Bewsey K., and Koepp H. Fibronectin fragment induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J 321 (1997) 751-757
9. Homandberg G.A., Hui F., and Wen C. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch Biochem Biophys 334 (1996) 325-331
10. Homandberg G.A., and Hui F. Arg-Gly-Asp-Ser peptide analogs suppress cartilage chondrolysis activities of integrin-binding and non-binding fibronectin fragments. Arch Biochem Biophys 310 (1994) 40-48
11. Homandberg G.A., Costa V., and Wen C. Fibronectin fragments active in chondrocytic chondrolysis can be chemically crosslinked to the alpha5 integrin receptor subunit. Osteoarthritis Cartilage 10 (2002) 381-393
12. Homandberg G.A., Costa V., and Wen C. Anti-sense oligonucleotides to the alpha5 integrin subunit suppress cartilage chondrolytic activities of amino-terminal fibronectin fragments. Osteoarthritis Cartilage 10 (2001) 381-393
13. Arner E.C., and Tortorella M.D. Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin 1. Arthritis Rheum 38 (1995) 1304-1314
14. Stanton H., Ung L., and Fosang A.J. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 364 (2002) 181-190
15. Loeser R.F., Forsyth C.B., Samarel A.M., and Im H.J. Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 278 (2003) 24577-24585
16. Homandberg G.A., Hui F., Manigalis C., and Shrikhande A. Cartilage chondrolysis caused by fibronectin fragments causes cleavage of aggrecan at the same sites as in osteoarthritis. Osteoarthritis Cartilage 5 (1997) 450-453
17. Lohmander L.S., Neame P.J., and Sandy J.D. The structure of aggrecan fragments in human synovial fluid: evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 36 (1993) 1214-1222
18. Abbaszade I., Lui R.Q., Yang F., Rosenfeld S.A., Ross O.H., Link J.R., et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274 (1999) 23443-23450
19. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Lui R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284 (1999) 1664-1666
20. Zeng W., Corcoran C., Collins-Racie L.A., Lavallie E.R., Morris E.A., and Flannery C.R. Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18. Biochim Biophys Acta 1760 (2006) 517-524
21. Collins-Racie L.A., Flannery C.R., Zeng W., Corcoran C., Annis-Freeman B., Agostino M.J., et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 23 (2004) 219-230
22. Curtis C.L., Hughes C.E., Flannery C.R., Little C.B., Harwood J.L., and Caterson B. n-3 Fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275 (2000) 721-724
23. Tortorella M.D., Malfait A.M., Deccico C., and Arner E. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 9 (2001) 539-552
24. Yamanishi Y., Boyle D.L., Clark M., Maki R.A., Tortorella M.D., Arner E.C., et al. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. J Immunol 168 (2002) 1405-1412
25. Arai M., Anderson D., Kurdi Y., Annis-Freeman B., Shields K., Collins-Racie L.A., et al. Effect of adenovirus-mediated overexpression of bovine ADAMTS-4 and human ADAMTS-5 in primary bovine articular chondrocyte pellet culture system. Osteoarthritis Cartilage 12 (2004) 599-613
26. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., and Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46 (2002) 2648-2657
27. Malfait A.M., Liu R.Q., Ijiri K., Komiya S., and Tortorella M.D. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277 (2002) 22201-22208
28. Pichika R., and Homandberg G.A. Fibronectin fragments elevate nitric oxide (NO) and inducible NO synthetase (iNOS) levels in bovine cartilage and iNOS inhibitors block fibronectin fragment mediated damage and promote repair. Inflamm Res 53 (2004) 405-412
29. Su S.L., Tsai C.D., Lee C.H., Salter D.M., and Lee H.S. Expression and regulation of Toll-like receptor 2 by IL-1beta and fibronectin fragments in human articular chondrocytes. Osteoarthritis Cartilage 13 (2005) 879-886
30. Homandberg G.A., Meyers R., and Williams J. Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. J Rheumatol 20 (1993) 1378-1382
31. Homandberg G.A., Kang Y., Zhang J., Cole A.A., and Williams J.M. A single injection of fibronectin fragments into rabbit knee joints enhances catabolism in the articular cartilage followed by reparative responses but also induces systemic effects in the non-injected joints. Osteoarthritis Cartilage 9 (2001) 673-683
32. Homandberg G.A., Ding L., and Guo D. Extracellular matrix fragments as regulators of cartilage metabolism in health and disease. Curr Rheumatol Rev 3 (2007) 183-196
33. Homandberg G.A., Hui F., and Wen C. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluids. Osteoarthritis Cartilage 6 (1998) 231-244
34. Zack M.D., Arner E.C., Anglin C.P., Altson J.T., Malfait A.M., and Tortorella M.D. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum 54 (2006) 2912-2922
35. 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 6 (1995) 725-740
36. 1 integrin stimulates the expression of cyclin-dependent kinases and DNA synthesis through activation of extracellular signal-regulated kinase. J Biol Chem 273 (1998) 1662-1669
37. Dalton S.L., Scharf E., Briesewitz R., Marcantonio E.E., and Assoian R.K. Cell adhesion to extracellular matrix regulates the life cycle of integrins. Mol Biol Cell 6 (1995) 1781-1791
38. Gemba T., Valbracht J., Alsalameh S., and Lotz M. Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment. J Biol Chem 277 (2002) 907-911
39. Forsyth C.B., Pulai J., and Loeser R.F. Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 46 (2002) 2368-2376
40. Pulai J.I., Chen H., Im H.J., Kumar S., Hanning C., Hedge P.S., et al. Nf-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 174 (2005) 5781-5788
41. Forsyth C.B., Cole A., Murphy G., Bienias J.L., Im H.J., and Loeser Jr. R.F. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 60 (2005) 1118-1124
42. Aota Y., An H.S., Homandberg G.A., Thonar E.J., Andersson G.B., Pichika R., et al. Differential effects of fibronectin fragments on the proteoglycan metabolism of intervertebral disc cells. A comparison with articular chondrocytes. Spine 30 (2005) 722-728
43. Homandberg G.A., Guo D., Ray L.M., and Ding L. Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone. Osteoarthritis Cartilage 14 (2006) 793-806
44. Homandberg G.A., and Erickson J.W. Model of fibronectin tertiary structure based on studies on interactions between fragments. Biochemistry 25 (1986) 6917-6925
45. Heremans A., DeCock B., Cassiman J.J., Van den Berghe H., and David G. The core protein of the matrix-associated heparan sulfate proteoglycan binds to fibronectin. J Biol Chem 265 (1990) 8716-8725
46. Xie D.L., Meyers R., and Homandberg G.A. Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 19 (1992) 1448-1452
47. Raymond L., Eck S., Mollmark J., Hays E., Tomek I., Kantor S., et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol 207 (2006) 683-688
48. Sylvester J., Liacini A., Li W.Q., and Zafarullah M. Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell Signal 16 (2004) 469-476
49. Pelletier J.P., Fernandes J.C., Brunet J., Moldovan F., Schrier D., Flory C., et al. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes. Arthritis Rheum 48 (2003) 1582-1593
50. Liacini A., Sylvester J., Li W.Q., and Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21 (2002) 251-262
51. Li W.Q., Dehnade F., and Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166 (2001) 3491-3498
52. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15 (1996) 2760-2770
53. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108 (2001) 73-81
54. Gille H., Kortenjann M., Thomae O., Moomaw C., Slaughter C., Cobb M.H., et al. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14 (1995) 951-962
55. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270 (1995) 7420-7426
56. Kawasaki H., Moriguchi T., Matsuda S., Li H.Z., Nakamura S., Shimohama S., et al. Ras-dependent and Ras-independent activation pathways for the stress-activated-protein-kinase cascade. Eur J Biochem 15 (1996) 315-321
57. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M., and Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 97 (1996) 2011-2019
58. Neuhold L.A., Killar L., Zhao W., Sung M.L., Warner L., Kulik J., et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 107 (2001) 35-44
59. Pei Y., Harvey A., Yu X.P., Chandrasekhar S., and Thirunavukkarasu K. Differential regulation of cytokine-induced MMP-1 and MMP-13 expression by p38 kinase inhibitors in human chondrosarcoma cells: potential role of Runx2 in mediating p38 effects. Osteoarthritis Cartilage 14 (2006) 749-758
60. Mengshol J.A., Vincenti M.P., Coon C.I., Barchowsky A., and Brinckerhoff C.E. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43 (2000) 801-811
61. Zhou Y., Millward-Sadler S.J., Lin H., Robinson H., Goldring M., Salter D.M., et al. Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model. Osteoarthritis Cartilage 15 (2007) 884-893
62. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. A. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98 (2001) 13681-13686
63. Berenbaum F. Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 16 (2004) 616-622